TRAIL-R1 Antibody [HS101] (FITC) | 36-125

TRAIL-R1 Antibody [HS101] (FITC) | 36-125 | Gentaur UK, US & Europe Distribution

Host: Mouse

Reactivity: Human

Homology: N/A

Immunogen: Recombinant human TRAIL-R1 (DR4) .

Research Area: Cancer, Immunology

Tested Application: Flow, ICC

Application: Functional Application: Inhibition. Immunohistochemistry: (frozen sections (1:150) ) . Immunoprecipitation: (10ug/ml) . Western Blot: (5ug/ml) .

Specificiy: Recognizes human TRAIL-R1. Does not cross-react with human TRAIL-R2, -R3 or -R4.

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: >95% (SDS-PAGE)

Clonality: Monoclonal

Clone: HS101

Isotype: IgG1

Conjugate: FITC

Physical State: Liquid

Buffer: Liquid. In PBS containing 0.02% sodium azide.

Concentration: 1 mg/ml

Storage Condition: Keep conjugated formats at +4˚C. Stable for at least 1 year after receipt when stored at +4˚C.

Alternate Name: TRAIL Receptor 1; DR4; APO2; TNFRSF10A; CD261

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: TRAIL-R1 is a receptor for the cytotoxic ligand TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappaB.